Papers
16
Total Citations
495
H-Index
10
About
Gus Miranda is a leading figure in the advancement of robotic surgery for bladder cancer, with a career dedicated to refining and standardizing robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD). His research focuses on replicating open surgical principles in a minimally invasive setting, demonstrating that complex reconstructive procedures can be performed entirely within the body. Miranda’s seminal work, including a two-institution study of 132 patients (125 citations), established the feasibility and safety of the robotic intracorporeal orthotopic neobladder. He has been instrumental in improving time efficiency during the learning curve and in proposing the "radical cystectomy pentafecta" (45 citations)—a standardized composite metric for reporting outcomes that integrates oncological adequacy with perioperative morbidity. His multi-center studies have provided long-term oncologic evidence supporting RARC with ICUD (51 citations), while his analyses of readmission patterns and the impact of body mass index have optimized patient selection and perioperative care. With over 470 total citations across his top ten papers, Miranda’s contributions have helped transform robotic cystectomy from a novel technique into a reproducible, evidence-based standard, improving recovery and quality of life for bladder cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10